Who's a good candidate
At this point, we suggest to better investigate the effect of different dosages by a randomized, double-blind placebo-controlled, longitudinal prospective trial, with three arms (placebo, ALCAR 3 g/day, ALCAR 1.5 g/day) and long-term follow up (12 months)
PMCID: PMC5816795
10.3389/fphar.2020.00425 Summary Keywords acute kidney injury, chuan huang fang, chronic kidney disease, renal fibrosis, reduced glutathione, traditional Chinese medicine Citation Chen L, Ye Z, Wang D, Liu J, Wang Q, Wang C, Xu B and Gong X (2022) Chuan Huang Fang combining reduced glutathione in treating acute kidney injury (grades 12) on chronic kidney disease (stages 24): A multicenter randomized controlled clinical trial